دورية أكاديمية
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
| العنوان: | The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL |
|---|---|
| المؤلفون: | Balakrishnan, KAff1, Aff2, IDleu2015105_cor1, Peluso, M, Fu, M, Rosin, N Y, Burger, J A, Wierda, W G, Keating, M J, Faia, K, O'Brien, S, Kutok, J L, Gandhi, VAff1, Aff2, IDleu2015105_cor11 |
| المصدر: | Leukemia. 29(9):1811-1822 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 08876924 14765551 |
|---|---|
| DOI: | 10.1038/leu.2015.105 |